The Bulfinch Companies
Bulfinch is a third-generation, family-owned Boston commercial real estate firm that acquires, develops, repositions, and self-manages approximately 4.4 million square feet of life science, medical office, office, and R&D properties across Greater Boston for institutional and corporate tenants.
- Company typePrivate
- Founded1936
- HeadquartersBoston, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What The Bulfinch Companies does
The Bulfinch Companies is a third-generation, family-owned commercial real estate firm founded in 1936 and headquartered in Boston, Massachusetts. The firm specializes in the acquisition, development, repositioning, and self-managed operation of commercial properties across Greater Boston, with a portfolio of approximately 4.4 million square feet and over $3.5 billion in assets under management. Its holdings span life science/lab (Cambridge Discovery Park, Osborn Triangle), medical office and wellness (Life Time Center, 5 Branch Street, Mount Auburn Place, 70 Hastings Street), general office (117 Kendrick Street, 25 New Chardon Street), and mixed-use/R&D (Chapel Bridge Park), with active development projects including the 475,000 SF Highland Innovation Center and the 73,000 SF 804 Huntington Avenue in Longwood Medical Area.
Bulfinch's revenue model is anchored in long-term, multi-year commercial leases — quote-based pricing negotiated on square footage, location, and tenant requirements — supplemented by self-performed property management, leasing, and development services. Tenant mix is deliberately diversified across life sciences (Pfizer, Novartis, LabCentral, Verastem, Biognosys, Dana-Farber), technology (Forrester, TripAdvisor, Siemens, Shark/Ninja), consumer (Warner Bros., First Aid Beauty, MUJI), healthcare systems, government (USPS), and coworking operators (Workbar). Distribution is direct via an in-house leasing team (Managing Director of Leasing, VP of Leasing, and a VP of Leasing hired March 2026), supplemented by brokerage partnerships (Newmark, Boston Realty Advisors) and an investor portal via Juniper Square. Properties are operated with in-house dedicated property managers per building, supported by facilities, engineering, construction, treasury, and asset management functions.
The firm competes on long-standing regional brand equity (90 years, NAIOP Developer of the Year 2007, REFA Swain Award 2021), prime submarket positioning in supply-constrained Cambridge/Kendall Square/Longwood/Chestnut Hill/Route 128 corridors, and extensive LEED/Energy Star/WiredScore/BOMA/Fitwel certifications across the portfolio. Recent activity (Q1 2026 lease volume of 350,000+ SF, June 2026 acquisition of 70 Hastings Street, Osborn Triangle energy retrofit with 83 EV chargers, JV with Harrison Street for the Natick Neiman Marcus repositioning, and internal expansion including nine promotions in April 2026) signals continued disciplined portfolio growth and reinvestment, executed within a conservative family-controlled ownership structure under CEO Eric D. Schlager and President Robert A. Schlager.
The Bulfinch Companies firmographics
Firmographics- Name
- The Bulfinch Companies
- Legal name
- The Bulfinch Companies, Inc.
- Website
- https://bulfinch.com
- Company type
- Private
- Founded year
- 1936
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Bulfinch is a third-generation, family-owned Boston commercial real estate firm that acquires, develops, repositions, and self-manages approximately 4.4 million square feet of life science, medical office, office, and R&D properties across Greater Boston for institutional and corporate tenants.
- Ownership category
- akta.pro rank
Where The Bulfinch Companies is headquartered
LocationHeadquarters
- HQ city
- Boston
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
The Bulfinch Companies business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D
Revenue model
- Commercial Property Leasing: Leasing of commercial real estate space including office, lab, medical office, retail, industrial, and residential properties across Greater Boston portfolio.
- Property Management Services: Self-management of properties with dedicated property managers providing first-class service, 24-hour accessibility, proactive maintenance, and efficient building operations.
- Real Estate Investment Returns: Acquisition and repositioning of commercial properties with focus on Central 128, Cambridge, Chestnut Hill, Brookline, and Boston markets. Transaction types include sale-leasebacks, adaptive re-use, repositioning projects, build-to-suits, new development, and redevelopment.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Quote-based commercial leasing |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels9 records
The Bulfinch Companies product offering
Product offeringCore offering
The Bulfinch Companies is a third-generation commercial real estate firm that acquires, develops, repositions, leases, and manages commercial properties across Greater Boston. The firm owns and operates approximately 4.4 million square feet of life science, medical office, office, retail, industrial, and residential space, offering tenants flexible, well-maintained workspaces through dedicated on-site property management.
Product overview
The Bulfinch Companies is a third-generation commercial real estate firm offering a comprehensive suite of property services organized around four core offerings: Commercial Property Leasing (flex, lab, industrial, office, life science, R&D, and medical office spaces), Property Management (self-managed operations with dedicated property managers), Commercial Real Estate Investments (acquisition services including sale-leasebacks, adaptive re-use, repositioning, build-to-suits, and redevelopment), and Development (lab, medical office, wellness, office, retail, industrial, and residential projects). The company owns and manages approximately 4.4 million square feet of life science, medical office, office and industrial assets across Greater Boston. Notable property portfolios include Cambridge Discovery Park (686,000 SF life science campus), Life Time Center (286,000 SF health and wellness center), Chapel Bridge Park (250,000 SF office/R&D campus), and Osborn Triangle (677,000 SF office and lab complex), alongside ongoing developments such as Highland Innovation Center and 804 Huntington Avenue.
Differentiator
Problem solved
Functional benefit
Products and services
- Commercial Property Leasing Leasing of commercial real estate space including flex, lab, industrial, general office, life science, R&D, and medical office spaces to enterprise tenants across the Greater Boston area.
- Property Management Self-managed property operations with proactive maintenance, 24/7 accessibility, and dedicated property managers assigned to each building in Bulfinch's portfolio.
- Commercial Real Estate Investments Acquisition of commercial properties including sale-leasebacks, adaptive re-use, repositioning projects, build-to-suits, new development, and redevelopment across Central 128, Cambridge, Chestnut Hill, Brookline, and Boston markets for institutional and private investors.
- Development Commercial real estate development services including lab, medical office, wellness, office, retail, industrial, and residential projects throughout Greater Boston, covering ground-up development, adaptive re-use, and repositioning.
- Cambridge Discovery Park A 686,000 SF LEED-certified life science campus in Cambridge comprising four buildings with amenities including an AC Hotel, restaurant, bar, and parking garage.
- Life Time Center A 286,000 SF LEED Gold-certified health, wellness, and medical center in Chestnut Hill, MA, anchored by Life Time Athletic and Dana-Farber Cancer Institute.
- Chapel Bridge Park A 250,000 SF office and R&D campus in Newton, MA spanning eight historic buildings with amenities including a cafeteria, fitness center, and EV charging stations.
- Osborn Triangle A 677,000 SF premier office and lab complex in Kendall Square, Cambridge, with three buildings and a 650-space parking garage, housing tenants including Pfizer, Novartis, and LabCentral.
Quantifiable outcome
- 350,000+ SF of lease transactions closed in Q1 2026
- +2 more outcomes
Companies that use The Bulfinch Companies
Customer profileNamed customers20 records
Segments5 records
Ideal customer profiles5 records
The Bulfinch Companies technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
The Bulfinch Companies partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core and minor.
- NewmarkcoreNewmark's retail brokerage team led by Matt Curtin, Greg Covey, and Alden Bush represented MUJI in the lease transaction at 48 Brattle Street. Bulfinch represented building ownership.
- Boston Realty AdvisorscoreBoston Realty Advisors' retail leasing team represented MUJI in the lease transaction at 48 Brattle Street in Harvard Square.
- Harrison StreetcoreIn partnership with Harrison Street, an affiliate of Bulfinch acquired the Neiman Marcus department store property in Natick in late 2021 with plans to reposition the property to meet current market demands. Bulfinch serves as developer and property manager for the 100,000 SF property.
- EversourcecoreWorking in close partnership with Eversource on energy efficiency improvements at Osborn Triangle campus. Eversource provided incentives and collaboration on sustainability upgrades including LED lighting, HVAC improvements, and EV charging stations. Bulfinch received over $1.7 million in Eversource and Mass Save incentives.
- Mass SavecoreCollaborated with Mass Save on comprehensive energy audits and efficiency improvements across Osborn Triangle campus. Partnership resulted in $1.7 million in incentives and significant sustainability upgrades.
- Commonwealth Electrical TechnologiesminorMechanical and electrical construction partner for Osborn Triangle energy efficiency upgrades including LED lighting, HVAC improvements, and EV charging station installation.
- J.C. CannistrarominorMechanical construction partner for Osborn Triangle sustainability improvements and building system upgrades.
- EMCOR GroupminorPartner on Osborn Triangle energy efficiency and sustainability projects.
- J.P. Morgan Private BankcorePartnership with J.P. Morgan Private Bank to establish the Bulfinch Engage Fund, a donor-advised fund for corporate philanthropy and charitable giving. The fund enables team members, friends, alumni and affiliates to contribute to social responsibility initiatives.
- National Philanthropic TrustcorePartner in the Bulfinch Engage Fund donor-advised fund, supporting the company's philanthropy and social responsibility efforts.
- Green City GrowersminorUrban agriculture partnership at Chapel Bridge Park campus. Tenants can join weekly gardening sessions, with harvest supplying the onsite café Sebastian's and going home with participants.
Scale indicators5 records
Recent moves8 records
Expansion highlights6 records
The Bulfinch Companies competitors and assessment
Company assessmentDirect peers
- Boston Properties (BXP): Boston Properties (BXP) is the largest publicly-traded office REIT in the U.S., headquartered in Boston and a direct competitor to Bulfinch in Greater Boston Class A office and life science. Both firms compete for the same premier Cambridge, Kendall Square, Longwood and Back Bay tenants with overlapping product offerings.
- Longfellow Real Estate Partners: Longfellow Real Estate Partners is a Boston-area specialist developer and operator of life science and innovation properties, with a portfolio across Greater Boston. Directly comparable to Bulfinch's lab/biotech development pipeline and Cambridge submarket focus.
- King Street Properties: King Street Properties is a Boston-area owner, developer and manager of life science and Class A office real estate, with concentrated Cambridge and Greater Boston exposure. Closely comparable to Bulfinch's Cambridge Discovery Park and Osborn Triangle life science focus and target tenant base (biotech, pharma).
- Beacon Capital Partners: Beacon Capital Partners is a Boston-based commercial real estate investment firm focused on office and life science properties in major U.S. markets. Directly comparable to Bulfinch in size, geography (significant Greater Boston exposure), strategy (value-add office/lab repositioning) and institutional LP-backed ownership.
- WS Development: WS Development is a Needham, MA-based commercial real estate firm specializing in mixed-use, retail, office and life science developments across Greater Boston. Comparable in geography, Greater Boston focus and multi-product (office, retail, lab) exposure to Bulfinch.
- The Davis Companies: The Davis Companies is a Boston-based vertically integrated real estate investment, development and management firm with office, lab and multifamily exposure in Greater Boston. Directly comparable to Bulfinch in Cambridge/Boston geography and value-add repositioning strategy.
- Leggat McCall Properties: Leggat McCall Properties is a long-standing Boston-based commercial real estate developer, owner and manager of office, lab and mixed-use properties in Greater Boston. Comparable in being a multi-generation Boston firm competing for the same institutional and life science tenants.
Broad incumbents
- Alexandria Real Estate Equities: Alexandria Real Estate Equities is a national, publicly-traded life science REIT with significant Cambridge/Boston lab presence. Overlaps with Bulfinch in Cambridge lab tenant base (Pfizer, Novartis) but operates at much larger scale across multiple U.S. life science clusters as a broad incumbent.
- Tishman Speyer: Tishman Speyer is a global commercial real estate investment, development and operating firm with a Boston-area office and life science portfolio. Overlaps with Bulfinch's Cambridge/Boston product set but operates as a broad global incumbent rather than a Greater Boston specialist.
- Related Companies: Related Companies is a national diversified real estate firm with office, lab, residential and mixed-use developments across major U.S. markets including Greater Boston. Comparable in mixed-product portfolio and development orientation but operates at significantly larger scale and broader geographic scope.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
The Bulfinch Companies social profiles
Digital presenceThe Bulfinch Companies compliance and trust
Trust signalCompliance24 records
The Bulfinch Companies financial estimates
Financial estimateRevenue estimate
Valuation estimate
The Bulfinch Companies leadership team
Management profileNumber of profiles
Profiles11 records
The Bulfinch Companies funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
The Bulfinch Companies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about The Bulfinch Companies
What does The Bulfinch Companies do?
The Bulfinch Companies is a third-generation commercial real estate firm that acquires, develops, repositions, leases, and manages commercial properties across Greater Boston. The firm owns and operates approximately 4.4 million square feet of life science, medical office, office, retail, industrial, and residential space, offering tenants flexible, well-maintained workspaces through dedicated on-site property management.
Is The Bulfinch Companies a public or private company?
The Bulfinch Companies is a private company. It is classified as family owned and is currently operating.
When was The Bulfinch Companies founded?
The Bulfinch Companies was founded in 1936. It employs 11 to 50 people.
Where is The Bulfinch Companies based?
The Bulfinch Companies is headquartered in Boston, United States, in the North America region.
How does The Bulfinch Companies make money?
Three revenue lines are on record. Commercial Property Leasing is the primary driver. The others are property Management Services and real Estate Investment Returns.
Who are The Bulfinch Companies's main competitors?
Direct peers on record are Boston Properties (BXP), Longfellow Real Estate Partners, King Street Properties, Beacon Capital Partners, WS Development, The Davis Companies and Leggat McCall Properties. Broad incumbents are Alexandria Real Estate Equities, Tishman Speyer and Related Companies.
Does The Bulfinch Companies have an API?
No public API is recorded for The Bulfinch Companies.